Neuren Pharmaceuticals Limited

NEU

Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. The company is headquartered in Melbourne, Victoria. The company went IPO on 2005-02-03. The firm is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The firm has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.

Vanguard Australian Shares Index ETF

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

iShares S&P 500 ETF

IVV

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

Findi Limited

FND

Findi Ltd. engages in the development of a digital payments business in India. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-08-08. The firm is a non-bank ATM operator. Its areas of focus include Payments and Digital Banking, Findi ATM Network, and Bank ATM Network. Under Payments and Digital Banking area of focus, it provides last-mile payments and digital banking solutions through its network of merchants facilitating banking and insurance services, utility payments, money transfers, e-commerce and train and airline tickets payments. Under Findi ATM Network area of focus, it operates its own branded network of ATMs which is integrated with its payments and digital banking merchant business. Under Bank ATM Network area of focus, it provides transaction payment solutions for both public and private sector banks across India with complete end-to-end ATM transaction processing and managed services capabilities. The firm is a Pan-Indian ATM operator and operates more than 14,000 branded ATMs and more than 189,000 active merchant outlets.

Betashares Australia 200 ETF

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 7577.73m in AUM and 198 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.